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Effects of Cholinergic Enhancement on
Visual Stimulation, Spatial Attention, and
Spatial Working Memory
of cholinergic modulation of bottom-up and top-down
processes, respectively (Sarter et al., 2001). An issue
that remains unaddressed is the manner in which cholin-
ergic modulation of these two types of processes com-
bine. There remains uncertainty as to whether top-down
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17 Queen Square modulation of sensory cortices is enhanced with cholin-
ergic stimulation (as might be expected given the facili-London WC1N 3AR
3 Department of Neurology tatory effects of acetylcholine on attention generally
[Sarter et al., 2001]) or whether it is suppressed, soCharing Cross Hospital
London W6 8RF as to favor bottom-up activity (suggested by cell layer
recording studies in sensory cortices [Hasselmo andUnited Kingdom
Cekic, 1996; Kimura et al., 1999] and computer modeling
of cholinergic effects [Yu and Dayan, 2002]).
One method to investigate this is with functional im-Summary
aging, which has demonstrated consistent neural corre-
lates of both bottom-up and top-down activity withinWe compared behavioral and neural effects of cholin-
ergic enhancement between spatial attention, spatial human visual cortex (e.g., Hopfinger et al., 2000). Although
previous studies have reported modulation of visual corti-working memory (WM), and visual control tasks, using
fMRI and the anticholinesterase physostigmine. Phy- cal activity as a result of cholinergic drug administration,
none have compared the effects of cholinergic modula-sostigmine speeded responses nonselectively but in-
creased accuracy selectively for attention. Physostig- tion on occipital activation between conditions of sen-
sory stimulation and attention while keeping stimulusmine also decreased activations to visual stimulation
across all tasks within primary visual cortex, increased constant. The anticholinesterase physostigmine has
been reported to increase extrastriate cortex activityextrastriate occipital cortex activation selectively dur-
ing maintained attention and WM encoding, and de- selectively during the encoding phase of a face working
memory (WM) task (Furey et al., 2000a) in which stimuluscreased parietal activation selectively during main-
tained attention. Finally, lateralization of occipital properties differed between phases. However, a more
recent fMRI study (Lawrence et al., 2002) observed thatactivation as a function of the visual hemifield toward
which attention or memory was directed was de- nicotine enhanced occipital activity similarly during two
levels of difficulty of a rapid visual information-pro-creased under physostigmine. In the case of attention,
this effect correlated strongly with a decrease in a cessing task. Consequently, enhancement of occipital
cortices may reflect a direct effect of nicotine on visual-behavioral measure of selective spatial processing.
Our results suggest that, while cholinergic enhance- evoked responses. We have also shown that physostig-
mine modulates neural correlates of attention in visualment facilitates visual attention by increasing activity
in extrastriate cortex generally, it accomplishes this cortex differently between face and nonface stimuli
(Bentley et al., 2003), which may reflect a bias of acetyl-in a manner that reduces expectation-driven selective
biasing of extrastriate cortex. choline toward processing stimuli of high intrinsic va-
lence (e.g., Acquas et al., 1996).
A related question regarding cholinergic function re-Introduction
lates to its role in memory processes. Behavioral disso-
ciations between attention and WM following choliner-The integrity of cholinergic afferents to cerebral cortex is
necessary for normal stimulus discrimination, selection, gic manipulation (in humans, e.g., Sahakian et al., 1993;
Park et al., 2000; and animals, e.g., Voytko et al., 1994)and vigilance (Robbins, 1998). During periods of high
attentional demand, acetylcholine is released diffusely support hypotheses that acetylcholine may mediate
throughout neocortex (Phillis and Chong, 1965) to mod- memory and attentional processes independently (e.g.,
ulate processing within both sensory and prefrontal- Everitt and Robbins, 1997; Ernst et al., 2001; Jones et
parietal cortices (Sarter and Bruno, 1997). Thus, cholin- al., 1992). However, it is likely that memory performance
ergic input to visual cortex has been shown to sharpen is at least partially cholinergically modulated by virtue
stimulus representations through a combination of sig- of cholinergic effects on attentional aspects of such
nal amplification and noise suppression (e.g., Sato et al., tasks (see Sarter et al., 2003). Hence, selective effects
1987; Murphy and Sillito, 1991). Additionally, cholinergic of physostigmine on WM encoding (Furey et al., 2000a)
afferents to prefrontal and parietal areas have been would be expected to reflect the actions of acetylcholine
shown to be critical for spatial orientation (e.g., Davidson on attention more generally, and where neural pro-
and Marrocco, 2000; Chiba et al., 1999) and sustained cesses are shared between attention and WM (e.g., Awh
attention (e.g., McGaughy and Sarter, 1998), especially et al., 1999; LaBar et al., 1999), we would expect these
in the presence of distractors (Gill et al., 2000). to be modulated by cholinergic manipulation in a simi-
The above effects have been characterised in terms lar fashion.
In the present study, we aimed to distinguish the ef-
fects of physostigmine on brain activation attributable*Correspondence: p.bentley@fil.ion.ucl.ac.uk
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Figure 1. Task Design and Peristimulus-
Evoked BOLD Responses
(A) Schematic time course of three tasks.
Each task type consisted of task-specific
stimuli at the beginning and end of every trial
and a variable intervening delay period (3–14
s of alternating checkerboard) that was iden-
tical in stimulus across tasks and in which no
motor response occurred. Transients at trial
start and end were modeled separately from
delay period for each task type, with each
task phase being convolved with its own ca-
nonical hemodynamic response function.
(B) Adjusted data from occipital cortex (aver-
aged over bilateral peaks plotted in Figure
5, under placebo) showing changes in BOLD
response across attention trials for varying
delay periods, temporally realigned to each
trial onset. Trials were divided according to
whether the initial cue was in the visual hemi-
field contralateral or ipsilateral to the occipital
side from which the data was acquired. Note
the increasing amplitude and duration of
BOLD activity with delay duration reflects de-
lay period activity (higher for attention to con-
tralateral than ipsilateral space), unlike re-
sponses to cue or target that are delay
independent. Effects reported in this paper
reflect the degree to which data fits a stan-
dardized delay-dependent regressor for each
trial type, similar to the actual profile of activ-
ity observed here for contralateral attention
(see Experimental Procedures).
to the main effect of attention from that due to stimulus Results
alone. An additional and orthogonal question was to
determine whether the differential occipital activation Behavioral Data
RT and accuracy measures for each subject were sub-engendered by selective spatial attention (e.g., Martinez
et al., 1999) and spatial working memory (Awh et al., mitted to separate repeated-measures ANOVAs with
factors of treatment (drug or placebo) and condition1999) toward either hemifield (versus the opposite hemi-
field) is itself modulated by physostigmine. We expected (attention, WM, and control; Figure 2). RT: subjects were
faster under physostigmine relative to placebo over allthat the degree of differential response between right
and left occipital cortices would either increase or de- conditions [F(1,17) 4.6; p 0.05; RTs comparing drug
to placebo for attention, WM, and control were 428 ver-crease, depending on whether cholinergic enhancement
positively or negatively modulated top-down spatial bi- sus 443 ms; 1014 versus 1047 ms, and 435 versus 457,
respectively], but there was no treatment  conditionasing of sensory cortices, respectively. Finally, we ex-
amined for brain regions that show either a dissociation interaction. A main effect of condition was also apparent
[F(1,17) 107; p 0.001], which could be predominantlyor similarity in response to physostigmine between at-
tention and working memory, including separate analy- accounted for by WM being slower than attention and
control (p  0.01). Accuracy: there was no main effectses of WM encoding and delay periods. Since our exper-
imental design aimed to control for sensorimotor effects of treatment for accuracy. However, a treatment con-
dition interaction was evident [F(1,17)  5.7; p  0.05],between conditions, we limited our analysis of choliner-
gic modulation of attention to the period of maintained which reflected physostigmine improving accuracy in
attention (86% versus 79% for valid trials; p  0.05) butattention between cue and target (which approximates
to the construct of “sustained attention”; see Sarter et not in WM (86% versus 87%) or control (98% versus
98%). An improvement in attention accuracy by drugal., 2001).
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Figure 2. Behavioral Results
Performance compared across conditions (at-
tention, working memory, and control; valid
and invalid cue trials are shown separately)
and treatments (placebo and physostigmine).
For RTs, a main effect of group existed, sug-
gesting faster responses under physostig-
mine (individual paired t tests for each task
revealed a significant effect only for atten-
tion). For accuracy, subjects performed bet-
ter under physostigmine during attention but
not working memory or control (at ceiling), as
suggested by a treatment  condition inter-
action. *p  0.05.
was also apparent if invalid trials were included or if no Within the attention condition, a selective spatial pro-
cessing bias toward cued versus uncued hemifields wasupper time limit for responses was set. A main effect of
condition was apparent [F(1,17)  48; p  0.001], with indicated by a faster performance (RT 435 versus 678
s; p  0.01) and greater accuracy (83.3 versus 62.6; pscores in control being higher than attention and WM
(p 0.01) and WM being higher than attention (p 0.05; 0.01) during validly versus invalidly cued trials. There
was no treatment validity interaction. Finally, we foundbut see interaction with treatment above).
Figure 3. Effect of Physostigmine on Visual Stimulation
Regions within occipital cortex showing main effect of visual stimulation (i.e., delay period activity across all tasks) versus baseline, under
placebo, physostigmine, and when comparing treatments for this effect (no occipital areas were greater under physostigmine than placebo
for the main effect of visual stimulation). Graphs plot percent signal change from baseline for the three conditions (separating attend right
and attend left conditions) in regions showing a main effect of visual stimulation under placebo. Primary visual cortex (calcarine sulcus)
showed greater stimulus-evoked activity under placebo than physostigmine, which did not differ significantly across conditions. This effect
was unlikely to be due to a general vascular effect of drug, as it was not seen in either lateral occipital cortex that also showed main effects
of visual stimulation under placebo (these regions can also be seen to show an effect of condition due to failure of activation during WM but
not attention or control).
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Figure 4. Effects of Physostigmine on Spatial Attention versus Control
Surface rendering of regions showing activity during delay periods of attention versus control tasks, under placebo, physostigmine, and when
comparing the two treatments for this effect. Graphs plot percent signal change from baseline for the three conditions (separating attend
right and attend left conditions) in regions from right and left occipital cortices showing enhancement of the attention versus control effect
under physostigmine. Both of these regions showed an enhancement of attention relative to control activity on both attend right and attend
left trials (**p  0.001, uncorrected). The superior-medial parietal region showing less activation under physostigmine for the same contrast
is also shown in yellow in Figure 6A.
no difference in the false alarm rate between treatments occipital cortices (p  0.05, whole-brain corrected). A
(overall mean  4.6%; 1.1%, and 1.6%, for attention, treatment effect was evident in primary visual cortex,
WM, and control, respectively). with physostigmine reducing stimulus-evoked activa-
tion compared to placebo (12, 90, 6; Z  4.01; p 
0.001, uncorrected; i.e., main effect of drug, with nofMRI Data: Effects of Physostigmine
treatment  condition interaction; Figure 3, graph 1).on Visual Stimulation
Lateral occipital cortices did not show a treatment effectWe first examined for visual regions showing stimulus-
(Figure 3, graph 2; treatment  region interaction com-evoked activation to the alternating checkerboard
paring primary visual and lateral occipital regions wasacross all three conditions (attention, working memory,
p  0.005), suggesting that physostigmine did not sim-and control delay periods) versus baseline. Under both
ply change hemodynamic responsiveness across occip-placebo and physostigmine, robust stimulus-evoked
activations were evident in primary visual and lateral ital cortex.
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Table 1. Regions Showing Effect of Attention versus Control, under Placebo, and Interaction of This with Physostigmine
Brain Region Peak Coordinates Z Score
Placebo: attention delay  control
R superior occipital 30 78 18 5.29
L superior occipital 24 75 30 4.10
L fusiform gyrus 39 66 6 4.20
R superior parietal 30 51 57 4.48
L superior parietal 15 66 54 5.60
L inferior prefrontal 36 21 3 5.10
48 6 33 4.39
R inferior prefrontal 30 27 12 4.30
Medial prefrontal 0 15 51 4.50
R dorsolateral prefrontal 24 0 57 4.49
L pulvinar 6 21 0 4.42
Drug  placebo: attention delay  control
R superior occipital 30 81 18 4.84*
L middle occipital 36 87 0 3.57*
L anterior prefrontal 36 54 6 3.81
R superior prefrontal 18 3 9 3.69
Placebo  drug: attention delay  control
R supero-medial parietal 6 54 57 3.95*
Regions showing main effect of spatial attention under placebo are restricted to those in which clusters are significant at p  0.05 (whole-
brain corrected; SPM thresholded at p  0.001, uncorrected). Treatment  condition interactions are thresholded at p  0.001, uncorrected;
*p  0.05, corrected for whole-brain, or 12 mm radius spheres centred on MNI coordinates derived from appropriate contrast in Hopfinger
et al., 2000. Simple effects of attention  control for strongest treatment level are also significant at p  0.001, except L anterior prefrontal
(p  0.01) and R supero-medial parietal (p  0.005).
fMRI Data: Effects of Physostigmine simple-effect analyses at the peaks of this treatment 
laterality interaction revealed that drug enhanced activ-on Spatial Attention
Spatial Attention versus Control ity (versus baseline, or control) on each occipital side
during ipsilateral cue (p  0.05; * in Figure 5A) but notUnder placebo, spatial attention versus control acti-
vated prefrontal, superior parietal, and superior occipital contralateral cue (not significant) trials.
Hence, during both attend-right and attend-left trials,cortices (Table 1 and Figure 4; note that the contrast is
limited to delay periods of both conditions, in which physostigmine enhanced the degree of activation (rela-
tive to control) in both ipsilateral and contralateral extra-stimulus was identical and no motor response oc-
curred). The direct comparison of this effect between striate occipital cortices, consistent with a drug-induced
enhancement of accuracy across both valid and invalidphysostigmine and placebo revealed that these regions
were differentially modulated by cholinergic enhance- trials. However, physostigmine was also found to in-
crease activation in (adjacent) extrastriate cortex thatment. Specifically, extrastriate occipital and prefrontal
cortices showed enhanced differential activity (blue in was greater on the side ipsilateral than contralateral
to the cued hemifield, resulting in a net reduction inFigure 4), while superior-medial parietal cortex (green in
Figure 4; yellow in Figure 6) showed reduced differential lateralization of occipital activity.
We next determined whether the physostigmine-activity, during attention relative to control, under phy-
sostigmine versus placebo. The drug-induced increases induced decrease in occipital lateralization bias with
selective spatial attention was associated with a reduc-in occipital activity with attention, relative to control,
were also significant (p 0.001) when analyzing attend- tion in a behavioral measure of selective spatial pro-
cessing. Taking each subject’s difference in accuracyright and attend-left trials separately (i.e., contralateral
and ipsilateral to cued direction; ** in Figure 4). between valid and invalid cued trials as an invalidity
effect, we found a highly significant correlation betweenRight versus Left—Spatial Attention
We next addressed the orthogonal question of whether drug-induced decrease of this behavioral measure and
attenuation in occipital activity lateralization reportedphysostigmine influenced the differential activation of
right versus left occipital cortices (and vice versa) as a above (r  0.70; p  0.001; Figure 5B; effect averaged
over bilateral occipital peaks of treatment  lateralityfunction of attended location. Under placebo, being
cued to either hemifield (versus the opposite hemifield) interaction). In other words, subjects showing greater
activation on the occipital side ipsilateral (versus contra-activated contralateral occipital cortex during the sub-
sequent delay period in which a uniform stimulus was lateral) to that cued, under drug, were more sensitive at
detecting invalidly (relative to validly) cued targets, un-presented (Table 2 and Figure 5A; Figure 1B demon-
strates how this effect reflects activity of the variable- der drug. Furthermore, those occipital regions manifest-
ing a physostigmine-induced enhancement specificallylength delay period rather than of the fixed-length initial
cue). Physostigmine was found to reduce the effect of during ipsilateral attention (versus control) showed a
correlation of this effect with drug-induced improvementselective spatial attention on differential occipital activa-
tion in both right and left occipital cortices. Post hoc in accuracy of invalid trials (r 0.51, p 0.05; Figure 5C;
Neuron
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Figure 5. Effects of Physostigmine on Right versus Left Spatial Attention and Vice Versa
(A) Surface rendering of visual regions showing activity during delay periods of attend-right versus attend-left and vice versa for placebo,
physostigmine, and the difference between treatments for these effects. Graphs plot percent signal change from baseline for the three
conditions (separating attend-right and attend-left conditions) in regions from right and left occipital cortices showing reduced differential
activity to attend-left versus right (and vice versa) under physostigmine relative to placebo. The physostigmine-induced reductions in differential
activity occurred as a result of physostigmine increasing activity during ipsilateral attended trials (*p  0.05) rather than due to drug-induced
effects during contralateral attended trials (not significant). Dashed line indicates peak activity observed in right superior occipital region from
Figure 4 (which was significantly greater than the peak activity depicted here). RVF, right visual field; LVF, left visual field.
(B) Scatter plot illustrates relationship between physostigmine-induced reduction in occipital lateralization and a behavioral measure of
physostigmine-induced reduction in stimulus selectivity. Values on x axis calculated as Placebo[contralateral  ipsilateral activity] 
Physostigmine[contralateral  ipsilateral activity], averaged over both occipital peaks showing treatment  laterality interaction. Values on y
axis calculated as Placebo  Physostigmine Invalidity Effect, where Invalidity Effect  valid trial  invalid trial accuracy.
(C) Scatter plot illustrates relationship between physostigmine-induced enhancement of delay period activity in occipital cortex ipsilateral to
cue location and accuracy on invalid trials. Values on x axis calculated as Placebo[ipsilateral  control activity]  Physostigmine[ipsilateral 
control activity], averaged over both occipital peaks showing equivalent treatment  condition interaction.
effect averaged over bilateral occipital peaks showing the fact that the peak signal estimates of both superior
occipital regions in Figure 5A were less (p  0.05) thantreatment  task interaction: 33, 87, 0 and 30, 81,
18). These BOLD-behavioral correlations, together with those observed elsewhere in superior occipital cortex
Cholinergic Modulation of Spatial Attention and WM
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Table 2. Regions Showing Effect of Lateralized Attention, under Placebo, and Interaction of This with Physostigmine
Brain Region Peak Coordinates Z Score
Placebo: RVF  LVF attention
L middle occipital gyrus 42 78 12 4.14
Placebo: LVF  RVF attention
R middle occipital gyrus 45 75 3 3.72
R fusiform gyrus 24 69 12 3.89
R lingual gyrus 9 81 9 3.53
L fusiform gyrus 36 93 9 3.91
Placebo  drug: RVF  LVF attention
L middle occipital gyrus 33 81 15 3.83
Placebo  drug: LVF  RVF attention
R middle occipital gyrus 24 81 18 3.53
RVF, right visual field; LVF, left visual field. Contrasts are thresholded at p  0.001, uncorrected. All regions are significant at p  0.05,
corrected for 12 mm radius spheres centered on MNI coordinates derived from similar contrasts in Martinez et al., 1999 (except for L lingual
gyrus). Simple effects of attention laterality for strongest treatment level are also significant at p  0.001 at all coordinates.
(e.g., Figure 4), argues against the possibility that a ceil- was also activated by attention versus control (delay-
periods), under placebo, as shown by a conjunctioning in the hemodynamic response could explain the
treatment  laterality interactions. analysis over the two tasks (i.e., regions significantly
active in both attention and WM: red in Figure 6A). How-
ever, whereas superior-medial parietal cortex hadfMRI Data: Effects of Physostigmine on Spatial
Working Memory shown an attenuated differential response to attention
versus control under physostigmine versus placeboSpatial Working Memory versus Control
The effect of working memory versus control (delay- (yellow in Figure 6A), there was no drug-induced modu-
lation of this area with WM versus control (treatment xperiods), under placebo, engendered activation in pari-
etal and prefrontal cortices (Table 3). A similar network condition interaction comparing attention and WM just
Table 3. Regions Showing Effect of Working Memory versus Control, under Placebo, and Interaction of This with Physostigmine and Showing
the Effects of Both Lateralized Attention and Lateralized Working Memory, under Placebo, and Interaction of These with Physostigmine
Brain Region Peak Coordinates Z Score
A.
Placebo: spatial WM1  control
R superior parietal 6 60 57 4.28*
L superior parietal 24 57 66 3.43
R dorsolateral prefrontal 27 3 60 4.16*
L inferior prefrontal 33 18 3 3.38
R inferior prefrontal 48 21 6 3.35
Drug  placebo: spatial WM  control
No areas reached significance
Placebo  drug: spatial WM  control
L inferior prefrontal 33 18 0 3.13
B.
Placebo: RVF  LVF (attention & WM)2
L superior occipital gyrus 18 87 27 5.46*
L inferior temporal gyrus 42 63 0 5.05*
L fusiform gyrus 15 84 15 4.88*
L occipital pole 12 96 6 3.43
Placebo: LVF  RVF (attention & WM)
R occipital pole 12 102 3 4.37*
R inferior temporal gyrus 45 66 3 3.85
Placebo  drug: RVF  LVF (attention & WM)
L middle occipital gyrus 39 78 12 4.97*
L fusiform gyrus 33 72 12 4.33*
L superior occipital gyrus 18 87 24 4.02
Placebo  drug: LVF  RVF (attention & WM)
R occipital pole 12 102 3 3.63*
R inferior occipital gyrus 36 87 3 3.11
Contrasts are thresholded at p  0.001, uncorrected; *p  0.05, corrected for whole-brain or for 12 mm spheres centred on MNI coordinates
derived from similar contrasts in Rowe and Passingham, 2001 (working memory) and Martinez et al., 1999 (attention laterality). Simple effects
of laterality for attention and WM under the strongest treatment level were significant at p  0.001, uncorrected, at all coordinates.
1 Effects presented in this table are restricted to delay periods of each task; see text for WM encode phase.
2 This contrast represents the conjunction of (RVF  LVF attention) and (RVF  LVF WM).
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Figure 6. Dissociation and Commonalities of Physostigmine Effects on Spatial Attention and WM
(A) Regions within superior parietal and prefrontal cortices showing increased activity to the conjunction of attention and working memory,
relative to control, under placebo (red). Superimposed is that parietal region showing greater differential activity to attention versus control,
under placebo relative to physostigmine (yellow). This region was not modulated by physostigmine during WM in spite of showing an even
greater effect of WM relative to control under placebo. Graph plots percent signal change from baseline for the three conditions in superior-
medial parietal region showing a treatment  condition (attention or WM) interaction (p  0.005). Values have been mean corrected with
respect to occipital regions (across groups) to facilitate interregional comparison.
(B) Surface rendering of visual regions showing activity during delay periods of both WM-right versus left (i.e., whether study items were
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fell short of conventional significance: 6, 63, 60; Z  Subjective, Physiological, and Eye Position Data
Subjects felt less alert after physostigmine relative to2.77; p 0.005, uncorrected). Additionally, those occipi-
placebo, comparing subjective rating scores (Bond andtal regions showing physostigmine-induced enhance-
Lader, 1974) between 0 and 40 min postinfusion (68%ment during attention versus control (Figure 4) showed
versus 75% alert, respectively; p 0.01). This replicatesno drug-modulation during WM-delay (treatment x con-
an effect observed in a separate study employing andition interactions comparing attention and WM peaked
identical physostigmine protocol (Bentley et al., 2003).at 33, 84, 18 and 27, 84, 21; Z  3.33; p  0.001,
Subjects were also more likely to develop dry mouthuncorrected). The only area showing an effect of drug on
(n  8), dizziness (n  7), and nausea (n  6; all p WM-delay (versus control) was in left inferior prefrontal
0.05; mean intensity out of 6  1, 0.6, 0.4, respectively)cortex that showed less differential activation under
under drug. There were no significant effects of drug onphysostigmine (a treatment x condition interaction com-
cardiovascular measures. Mean saccade frequency wasparing attention and WM also occurred in this region:
8% in attention, 3% in working memory, and 1% inphysostigmine increased responses to attention versus
control delay periods; median eye position was 0.5WM: 39, 21, 3; Z  3.49; p  0.001, uncorrected).
from fixation in all sessions. There were no treatmentRight versus Left—Spatial Working Memory
effects for either eye position measure.Subjects demonstrated selective occipitotemporal acti-
vation both on the side contralateral to that in which
Discussion
study items had been presented during the WM task
and contralateral to the side that had been cued during The present study examined for similarities and dissoci-
the attention task, as revealed by a conjunction analysis ations in behavioral and brain responses to cholinergic
over the delay periods of both tasks under placebo (Fig- enhancement between spatial attention, spatial working
ure 6B, left, and Table 3). We hypothesized that if spatial memory, and visual stimulation. By designing all tasks
attention and spatial WM employed a common occipital with a variable-duration, stimulus-identical delay period
mechanism (see Awh and Jonides, 2001), then any cho- we were able to compare pharmacological actions be-
linergic modulation of differential occipital activation ob- tween the cognitive effects of interest (viz. the delay
served with the contrast of attended location would also components of each task) while eliminating sensorimo-
be found with the contrast of WM location. A between- tor differences between conditions or treatments (see
treatment comparison of regions showing differential Experimental Procedures). Furthermore, the design en-
activation to laterality of both attention and WM (i.e., abled us to test hypotheses regarding the effects of
right versus left and vice versa, for both types of task) cholinergic enhancement on top-down biasing of sen-
sory cortices during attention and WM (e.g., Yu andrevealed that physostigmine reduced the degree of se-
Dayan, 2002) and on the similarity of cholinergic actionslective contralateral occipital activation for both tasks,
between attention and WM encoding (e.g., Sarter etin right and left hemispheres (Figure 6B, right, and Table
al., 2003).3; neither area showed a treatment  condition inter-
Physostigmine enhanced accuracy for attention butaction).
not WM while causing a speeding of response indepen-Encoding
dent of task. Effects of physostigmine on BOLD activityA previous WM study (Furey et al., 2000a) found that
that were selective for attention rather than WM or con-physostigmine enhanced extrastriate occipital activity
trol delay periods were evident in extrastriate occipitalselectively with face encoding (i.e., study versus test
and prefrontal cortices (physostigmine increased thephases), which was interpreted as an effect of choliner-
effect of attention versus control) and superior-medialgic enhancement on attention. We were able to test
parietal cortex (physostigmine decreased the same ef-
for this possibility in our experiment by examining for
fect). Conversely, effects of physostigmine on brain re-
regions that showed drug-induced enhancement during sponses that were similar across tasks were found in
both WM study (versus WM test) and attention delay primary visual cortex (physostigmine reduced re-
(versus control delay), using a conjunction analysis over sponses to attention, WM, and control-delay periods).
both types of effect. This revealed that bilateral occipital Furthermore, cholinergic modulation of attention and
(30, 81, 18 and 24, 84, 12, Z  3.45) and superior WM was similar in the two following respects: physostig-
parietal (27, 63, 33, Z  4.01; p  0.001, uncorrected, mine reduced selective occipital activation during both
for all) cortices showed enhanced activity under physo- attention and WM-delay periods (as a function of pre-
stigmine selectively during both WM encoding and at- ceding cue or study item laterality) and increased activa-
tention (Figure 6C). No visual regions showed the oppo- tions during both WM-encoding and attention-delay in
the same extrastriate regions.site contrast (i.e., reduction of both contrasts by drug).
presented in right or left visual field) and attend-right versus left and vice versa, as revealed by a conjunction analysis of laterality effects
over both tasks, for placebo, physostigmine, and the between-treatment effect. Graphs plot percent signal change difference between trials
in which attention or WM were directed contralaterally versus ipsilaterally to each occipital side. Plots are from those coordinates showing
the maximal treatment  laterality interaction (ringed) and demonstrate similar physostigmine-induced reductions in selective occipital
activation with both attention and WM.
(C) Surface rendering of visual regions showing physostigmine-induced enhancement of both attention delay (versus control delay) and WM
encode (versus WM test) contrasts. Graphs plot percent signal change difference for both contrasts under placebo and physostigmine, in
those occipital coordinates showing the maximal treatment effect on both contrasts (ringed).
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We discount any explanation of our findings in terms relevant stimuli presented for an equally brief duration
(attention varying as a function of target number andof general effects of drug on blood oxygenation level-
dependent (BOLD) responses. First, all task effects were semantics), whereas in our study targets differed mark-
edly in properties between attention and control. Hence,corrected for session means, which themselves did not
differ by treatment across any of the areas highlighted the enhancement of occipital activation by procholiner-
gic modulation may depend upon the difficulty of de-(nor were there treatment effects on global activity or
blood pressure). Second, certain treatment  condition tecting task-relevant stimuli as well as on attentional
demand. We caution that the use of nicotine, in smokers,interactions (Figures 4–6) can only be explained by re-
course to an effect of drug on specific cognitive pro- in Lawrence et al. makes these two studies not
strictly comparable.cesses. In the case of drug effects across all tasks (Fig-
ure 3), we note that the effect reported was specific to
only one part of visual cortex, arguing against a general Cholinergic Modulation of Spatial Working Memory
change in occipital BOLD responsiveness. Finally, while In contrast to the wide effects of physostigmine on at-
a BOLD response ceiling could potentially explain a re- tention-delay (versus control), physostigmine’s modula-
duced occipital lateralization under drug, we argue tion of working memory-delay (versus control) was re-
against this on the basis of a behavioral correlation with stricted to inferior prefrontal cortex (see also Furey et
this effect and the observation that peak responses al., 2000a). Notably, physostigmine reduced the effect
within the interaction were significantly less than those of attention-delay but not WM-delay in superior-medial
in contiguous occipital regions. parietal cortex, in spite of both conditions activating this
region similarly under placebo. This pattern of activity
could be explicable, as for occipital cortex, either inCholinergic Modulation of Visual Stimulation
terms of differing acetylcholine release between condi-and Spatial Attention
tions or as a difference in input to parietal cortex fromOur findings of cholinergic modulation of occipital cor-
other regions (occipital and prefrontal cortices weretex that occurred both selectively with attention (in
more extensively activated under attention than WM).extrastriate cortex) and independent of task (in striate
Physostigmine also enhanced activity selectively withcortex, during visual stimulation) support a model in
attention-delay but not WM-delay in occipital and pre-which acetylcholine acts on both task-driven (top-down)
frontal cortices.and stimulus-driven (bottom-up) sensory processes
These selective actions of physostigmine on delay(see Sarter et al., 2001). The observed depression of
period activity during attention but not WM parallel thevisual-evoked BOLD activity by physostigmine in early
observed behavioral effect: accuracy improved withvisual cortices is consistent with previous functional im-
drug under attention but not WM, in spite of both tasksaging studies (Bentley et al., 2003; Mentis et al., 2001;
showing similar baseline performance levels (under pla-Grasby et al., 1995; Thiel et al., 2001) and may reflect
cebo, attention was performed slightly less accuratelyeffects of acetylcholine in primary sensory areas on fil-
but faster than WM). Our pattern of neuroimaging resultstering noise (e.g., Sato et al., 1987; Murphy and Sillito,
may also underlie results of studies in animals (Chappell1991) and inhibiting feedback from higher centers (Has-
et al., 1998; Baxter et al., 1996; Herremans et al., 1996)selmo and Cekic, 1996; Kimura et al., 1999).
and humans (Heishman et al., 1994), including Alzhei-Where physostigmine acted on extrastriate occipital
mer’s disease (Sahakian et al., 1993; Jones et al., 1992),cortex selectively during attention, this may have oc-
in which cholinergic manipulations produced relativelycurred by one (or both) of two means. First, cortical
selective effects on attention rather than short-termacetylcholine release is boosted more during attention
memory. Where cholinergic drugs have been observedthan other conditions (e.g., Himmelheber et al., 2000),
to exert specific effects on WM, these may have beenwhich would allow physostigmine to have a greater ob-
due to the employment of more demanding tasks thanserved local effect. Although the response profile in cal-
used here (Robbins et al., 1997; Rusted and Warburton,carine sulcus argues against this (i.e., nonselective phy-
1988) or due to testing smokers (Park et al., 2000).sostigmine modulation), this may reflect the fact that
In a face-WM study by Furey et al. (2000a), using aprimary, relative to higher, sensory areas possess
drug protocol identical to ours, extrastriate cortex wasgreater concentrations of cholinergic receptors (Mash et
found not to exhibit cholinergic modulation during WM-al., 1988; Prusky et al., 1988), and hence, the cholinergic
delay (as we found) but was positively modulated byresponsiveness of primary sensory regions may be ex-
physostigmine during WM-encoding. One interpretationpressed at lower concentrations of acetylcholine. Sec-
was that physostigmine was acting specifically whenond, physostigmine may have acted upon higher pro-
enhanced attention needed to be paid toward a stimuluscessing centers (as we found in superior parietal and
(see also Sarter et al., 2003). Our results lend supportprefrontal cortices) specifically engaged by attention,
to this idea by finding extrastriate occipital regions thatwhich may then indirectly augment activation in sensory
enhanced their response under physostigmine both dur-regions (Gill et al., 2000; Sarter et al., 2001).
ing attention-delay and WM-encoding but not duringIn a recent fMRI study employing the rapid visual
WM-delay or control-delay.information-processing task, nicotine was observed to
enhance extrastriate occipital cortex similarly under two
levels of difficulty (Lawrence et al., 2002). While this Cholinergic Modulation of Task-Driven
Occipital Lateralizationseems to contradict our findings of selective actions of
physostigmine on attention, it is notable that the two Previous studies have demonstrated selective activa-
tion of retinotopic occipital cortex depending on theconditions in the Lawrence et al. study employed task-
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location at which either attention (e.g., Martinez et al., periods of other conditions) in extrastriate cortex. How-
ever, while the overall level of extrastriate cortex activa-1999) or working memory (Awh et al., 1999) is directed,
independent of stimulus. Since acetylcholine has been tion was raised under physostigmine with attention, the
expectation-driven selectivity of activation in the sameproposed to be a critical modulator of top-down (task-
driven rather than stimulus-driven) effects (see Sarter region was reduced. These last two (orthogonal) effects
were associated with consistent behavioral effects:et al., 2001), we expected to find either an increase
or decrease in selective occipital activation during the subjects’ scores were higher with physostigmine over
all attention trials, but subjects showing greater drug-delay period of both tasks, depending on whether the
net effect of acetylcholine was to increase or decrease, induced reduction in occipital lateralization showed a
relatively greater benefit during invalid than valid trials.respectively, top-down biasing of sensory processing.
We emphasize that this effect is orthogonal to the main Hence, while attentional engagement of higher visual
cortex may increase under cholinergic enhancement,effect of physostigmine on attention versus control (that
was increased under drug). Our results show that physo- the retinotopic selectivity of occipital activation that
characterises selective spatial attention may itself di-stigmine reduced the degree of occipital lateralization
associated with both attention and WM, in both hemi- minish (at least in the hypercholinergic state, given that
our subjects were healthy young adults).spheres. For attention, this effect was due to physostig-
mine increasing activation disproportionately more on Our study also identified differences and similarities
between cholinergic modulation of attention and work-the side ipsilateral than contralateral to the previously
cued hemifield (i.e., it favored activation more on the ing memory. Selective effects of physostigmine on at-
tention delay period activity in extrastriate occipital andoccipital side representing the visual hemifield in which
targets were less expected). Furthermore, the actions superior-medial parietal cortices paralleled a pharmaco-
logical dissociation on accuracy between tasks. How-of physostigmine on occipital lateralization and activa-
tion of ipsilateral occipital cortex were correlated with ever, physostigmine exerted effects on extrastriate cor-
tex that were similar between attention and WM,concordant behavioral effects (viz. with a reduction in
performance discrepancy between valid and invalid tri- specifically with analyses of WM encoding rather than
delay (see also Furey et al., 2000a) and with task-drivenals and an increase in invalid trial accuracy, respec-
tively), suggesting that cholinergic modulation of oc- lateralization of occipital responses. These findings sup-
port proposals that cholinergic effects on short-termcipital lateralization had effects on selective spatial
processing. memory are mediated primarily through attentional as-
pects of such tasks (e.g., Sarter et al., 2003) and, moreThe results provide a neural explanation for psycho-
pharmacological studies showing that cholinergic neu- generally, provide additional evidence for there being
neural processes common to attention and workingrotransmission inversely correlates with the cost engen-
dered by invalid cues (Stewart et al., 2001; Phillips et memory (Awh and Jonides, 2001).
al., 2000; Witte et al., 1997; Chiba et al., 1999) and are
Experimental Proceduresrelevant to the hypothesis that the hypercholinergic
state is associated with heightened processing of irrele-
Subjects
vant information, e.g., as in anxiety (Berntson et al., Eighteen right-handed volunteers (13 female, 5 male; mean age 
1998). Preferential enhancement of sensory-cortical re- 23.4 	 1.0) with no history of medical or psychiatric disease gave
sponses to behaviorally irrelevant (relative to relevant) written informed consent. No subject was on medication or a
smoker. Each subject participated in two sessions separated bystimuli under physostigmine has also been observed in
7–10 days, performed at similar times of the day. Subjects receiveda fear-conditioning paradigm (Thiel et al., 2002), sug-
a physostigmine or placebo (saline) infusion on different sessions,gesting that cholinergic modulation of attentional pro-
with treatment order being counterbalanced across subjects. Three
cessing may have subsequent effects on learning. To- further subjects that were scanned were excluded due to excessive
gether, these findings speak to models (Yu and Dayan, saccades (50% trials).
2002; Hasselmo and Cekic, 1996) in which the role of
neocortical acetylcholine is to favor feedforward (or Drug Treatment
A double-blind placebo-controlled drug administration techniquestimulus-driven) over feedback (e.g., expectation or task-
was used. Each subject received an intravenous cannula into theguided) sensory processing, especially during periods
left cubital fossa and an infusion of either physostigmine or saline,of uncertainty. Our observation of preferential enhance-
depending on session. Dosage and rate of physostigmine infused
ment on the occipital side ipsilateral to cued direction was identical to that used in a recent study (Furey et al., 2000b),
under physostigmine (with no occipital enhancement providing stable levels of plasma drug concentration and butyryl-
cholinesterase inhibition as well as a significant and stable effectunder low-attention control) could be explained in terms
on cognitive performance for 40 min, following a 40 min loadingof reduced feedback to sensory cortices (e.g., Hasselmo
period. The same drug protocol has also been found to result inand Cekic, 1996; Kimura et al., 1999) if it were the case
changes in task-specific occipital activity using fMRI, with workingthat such feedback suppression occurred preferentially
memory (Furey et al., 2000a) and perceptual attention (Bentley et
on the inhibitory pathways that underlie selective spatial al., 2003) tasks.
attention (e.g., Chelazzi et al., 2001). During the drug session, subjects were first given 0.2 mg intrave-
nous glycopyrrolate (peripheral muscarinic receptor antagonist) be-
fore an intravenous infusion of physostigmine was commenced (1.93Conclusions
mg/hr for 10 min, followed by 0.816 mg/hr for 40 min). Subjects thenPhysostigmine reduced visual-evoked activity in striate
performed the task in the scanner while receiving a constant rate
cortex (possibly relating to neurophysiological evidence of drug for a further 40 min (1.3 mg physostigmine in total deliv-
for net noise suppression) while enhancing activation ered). In the placebo session, an equivalent volume of saline was
administered in all steps. On both sessions, blood pressure wasselectively with maintained attention (relative to delay
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checked before and at 40 min into infusion, while pulse-oximetry and median eye position were monitored during each delay period
(using an infrared eye tracker: ASL Model 540, Applied Sciencewas performed continuously. Subjects were given a questionnaire
at 0 and at 40 min postinfusion that allowed a ranked measurement Group Co., Bedford, MA; refresh rate 60 Hz); trials in which central
fixation did not occur were discounted from the behavioral and(0–6 scale) of seven recognized adverse reactions to physostigmine
and glycopyrrolate as well as a list of visual analog scales for esti- imaging analysis.
mating subjective feelings (Bond and Lader, 1974).
Imaging and Image Processing
Task MRI data were acquired from a 2T VISION system (Siemens, Er-
On each session, subjects performed three tasks (spatial attention, langen, Germany) equipped with a head coil. Functional images
spatial working memory, and visual control; Figure 1) in different were acquired with a gradient echo-planar T2* sequence using
blocks and repeated once (e.g., AWCAWC). To minimize order ef- BOLD (blood oxygenation level-dependent) contrast. The acquired
fects, treatment and task order were completely counterbalanced image consisted of 33  3 mm thickness axial slices that covered
across subjects, with task order being repeated across sessions. the entire brain, with an effective repetition time of 2.51 s. The first
Furthermore, on each session, subjects were given half-hour prac- six volumes were discarded to allow for T1 equilibration effects.
tice with feedback, outside the scanner, prior to drug delivery, and Images were realigned to the first scan of the first session, time
were also given 10 min inside the scanner, prior to actual task, to corrected, normalized to a standard echo-planar image template,
accustom subjects with scanner environment and noise. There were and smoothed with a Gaussian kernel of 8 mm full-width half-
52 trials of each condition per session, with an ITI of 0.5–3.5 s. maximum.
In the attention task, subjects were cued to either right or left
visual hemifields (for 2.1 s) before being presented with a 12 Hz
alternating, polarized checkerboard (18 height  22 width; vertical Statistical Analysis of Images
Data were analyzed with a general linear model for blocked, event-wedges removed) for 3–14 s (mean  7.8 s; approximate Poisson
distribution). After this delay period, two adjacent “squares” on ei- related designs (SPM99; Wellcome Department of Cognitive Neurol-
ogy, London, UK; Friston et al., 1995) using a random-effects analy-ther the right or left side of the checkerboard (6 eccentricity; 3
wide, within 45 arc about horizontal meridian) reversed in polarity sis. Data were globally scaled and high-passed filtered at 1/256 Hz.
For each subject and session, the following events and epoch types(the target, appearing as a “hole” within the checkerboard) for 84
ms, before being replaced by the normal checkerboard for a further were modeled separately: attention cue (R and L, separately), atten-
tion delay (R and L), attention target (R and L, and for each, valid2.5 s. Subjects were required to attend to the cued side covertly
(i.e., while fixating centrally) and to press either right or left buttons, and invalid), WM study (R and L), WM delay (R and L), WM probe,
control cue, control delay, control target (all control trials were arbi-depending on target side, immediately on seeing the target, with
the right hand. By only including responses within 1.5 s of target trarily divided into two to allow for independence in a conjunction
analysis of attention and WM versus control), false alarms, and(accounting for 95% responses), a measure of accuracy could be
obtained (since 27% accuracy could occur by subjects simply saccades or eye deviation (R and L). In those attention trials in which
the target was missed, the modeled delay period was extended untilpressing after the commonest delay period). Targets either ap-
peared on the same (valid trials: 80%) or opposite (invalid trials: the end of the checkerboard presentation. All modeled events and
epochs were convolved by a canonical hemodynamic response20%) side to that cued.
Working memory trials began with a study phase in which three function; temporal derivatives of these functions were modeled sep-
arately (Friston et al., 1998). The six head movement parameterspoints were presented successively (for 700 ms each) in one of 24
equally spaced locations in either right or left visual hemifields (each were included within the model as confounding covariates.
In order to control for sensorimotor differences between condi-equivalent to half the checkerboard area). Subjects were then re-
quired to rehearse the locations of the three points while fixating tions and performance between treatments, only contrasts of delay
period activity were made (except for testing of drug effects oncentrally during presentation of a 3–14 s alternating checkerboard
(parameters as for attention task). Following this period, a probe WM encoding—see below). Differences in BOLD signal magnitude
between conditions of interest (viz. delay period of all tasks versuspoint appeared anywhere in the display (for 2.5 s), and subjects had
to indicate whether its location was the same as one of the three baseline; attention delay versus control delay; WM delay versus
control delay; attention right delay versus attention left delay andstudied points (test phase). The WM task is adapted from a blocked
fMRI study (Awh et al., 1999) in which lateralized occipital responses vice versa) were calculated for each subject and treatment before
being submitted to one-sample t tests with generation of statistical(regions of interest) were found contralateral to the visual field in
which studied items were presented during a spatial but not object parametric maps (SPMs) of the t statistic. Comparisons of these
contrasts were then made between treatments (treatment  condi-WM task.
Visual control trials resembled attention and WM trials in temporal tion interactions). The interaction of treatment condition, compar-
ing specifically attention with WM, was restricted to within 12 mmcomposition, with a 3–14 s delay period of alternating checkerboard,
during which subjects fixated centrally. However, trials began with (the estimated smoothness) of those coordinates also showing inter-
actions of treatment  condition comparing either attention or WMa central cue for 2.1 s and ended with a prominent central triangle
on a plain background for 2.5 s, at which subjects had been in- with control. In order to test for regions showing both attention and
working memory activity, contrasts of each condition versus its ownstructed to press the first key, with no emphasis on speed (hence
requiring minimal attention). set of control trials, under placebo, for each subject were submitted
to repeated-measures ANOVA corrected for nonsphericity (Glaser etThe use of variable-duration delay periods enabled us to model
this temporal component of brain activity (in which the stimulus al., 2001). A conjunction analysis was then performed over contrasts
from both conditions (Price and Friston, 1997). Similar analyses wereremained identical across conditions and there was no motor re-
sponse) separately from transients at either end of the delay period performed to test the hypotheses that physostigmine modulates
selective occipital activation with both spatial attention and spatial(which varied between conditions and group—the latter due to drug
effects on response). By employing a wide range of delay durations WM laterality, and that physostigmine modulates both attention
(attention delay versus control delay) and WM encoding responsesand modeling the delay periods of false alarm and saccade trials
separately, the modeled time series of transients and delay periods (study versus test phases) in the same regions. We report areas
that achieve p  0.05 significance after correction for whole brain(derived from convolving successive stimulus boxcars with the he-
modynamic response function) are sufficiently decorrelated to en- or 12 mm radius spheres centered on MNI coordinates derived
from equivalent contrasts in previous nonpharmacological studiesable efficient estimation of the independent effects of each task
component (see also Rowe and Passingham, 2001). Shared variance (Hopfinger et al., 2000, for main effect of attention; Martinez et al.,
1999, for attention laterality; Rowe and Passingham, 2001, for mainbetween transient and delay period regressors is effectively ex-
cluded from estimation of the individual effects within the general effect of WM delay). We also list areas surviving a threshold of p 
0.001, uncorrected. Reported interactions (treatment  condition)linear model and amounted to less than 8% and 16% across all
initial delay and delay response pairings, respectively. Saccades are also significant for the simple effect of condition under the
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strongest treatment effect (p  0.001, uncorrected), except where Furey, M.L., Pietrini, P., Alexander, G.E., Mentis, M.J., Szczepanik,
J., Shetty, U., Greig, N.H., Holloway, H.W., Schapiro, M.B., and Freo,indicated in the tables.
We emphasize that the drug effects reported here are task spe- U. (2000b). Time course of pharmacodynamic and pharmacokinetic
effects of physostigmine assessed by functional brain imaging incific, as mean session effects are modeled separately. All regions
that showed significant treatment-by-condition interactions were humans. Pharmacol. Biochem. Behav. 66, 475–481.
found to show insignificant between-treatment session effects (p  Gill, T.M., Sarter, M., and Givens, B. (2000). Sustained visual atten-
0.10, uncorrected). Furthermore, the global session-mean activity tion performance-associated [medial] prefrontal neuronal activity:
did not differ between treatments (p 0.10), suggesting that physo- evidence for cholinergic modulation. J. Neurosci. 20, 4745–4757.
stigmine did not engender significant general vascular effects.
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